Groww Logo
Home>IPO>Supriya Lifescience Ltd.

Supriya Lifescience IPO

Supriya Lifescience Ltd.

₹14,310 /54 sharesMinimum Investment

Supriya Lifescience IPO Listing Details

Listed OnIssue PriceListing PriceListing Gains
BSE & NSE₹274.00₹421.00₹147.00 (53.65%)

Supriya Lifescience IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
16 Dec ‘21 - 20 Dec ‘21₹14,31054₹265 - ₹274
Issue SizeIPO Doc
700.00Cr
RHP PDF

Subscription Status As on 20 Dec '21, 8:00 PM

  • Retail Individual Investor
    56.01x
  • Non-Institutional Investor
    161.22x
  • Qualified Institutional Buyers
    31.83x

About Supriya Lifescience

Supriya Lifescience supplies active pharmaceuticals ingredients (APIs), with a focus on research and development. It has
Parent Organisation
Supriya Lifescience Ltd.
Founded
2008
Managing Director
Satish Waman Wagh
Supriya Lifescience IPO Review, Date,Price,Details | Aleena Rais | Latest IPO news | Upcoming IPO

Strengths & Risks

  • Significant scale with a leadership position across key & niche products.
  • A backward integrated business model that ensures a steady supply of intermediaries.
  • Geographically diversified revenues with a global presence across 86 countries.
  • Advanced manufacturing and research and development capabilities.
  • Consistent strong financial performance due to a de-risked business model.
  • Any reduction in demand for a set of products that the company relies on for a significant portion of its revenue.
  • Dependence on a few customers for a significant portion of revenue.
  • Its international operations expose it to complex management, legal, tax, and economic risks.
  • Failure to successfully develop or commercialise new products in a timely manner.
  • Any failure to comply with regulations prescribed by governments and regulatory agencies or obtain, maintain, or renew its statutory and regulatory licenses, permits, and approvals required to operate its business.
  • Any manufacturing or quality control problems.
  • Non-compliance with and changes in, safety, health, environmental, and labor laws and other applicable regulations.
  • Any delay in production at, disruption or shutdown of its manufacturing facility, or failure to achieve optimal capacity utilisation.
  • Changes in technology may render its current technologies obsolete or require it to make substantial capital investments..
  • Inability to accurately forecast demand for its products and manage its inventory.
  • Inability to patent new processes and protect its proprietary information or other intellectual property.

Financials

*All values are in Rs. Cr
No Graph Data To Display

Top IPO FAQs

What is the issue size of Supriya Lifescience Limited IPO?

Supriya Lifescience Ltd. IPO issue size is a fresh issue of Rs 200.00 crores and an offer for sale of Rs 500.00 crores

What is 'pre-apply' for Supriya Lifescience Limited IPO?

Pre-apply will alow you to apply for the Supriya Lifescience Limited IPO 2 days before the subscription period starts.

If I pre-apply for Supriya Lifescience Limited IPO, when will my order get placed?

Your order will be placed on the exchange as soon as the Supriya Lifescience Limited IPO bidding starts. You will receive a UPI request within 24 hours after the bidding period opens.

When will I know if my Supriya Lifescience Limited IPO order is placed?

We will notify you when your Supriya Lifescience Limited IPO order is placed with the exchange.

What are the open and close dates of the Supriya Lifescience Limited IPO?

Supriya Lifescience Limited IPO date is December 16 to December 20, 2021.

What is the lot size and minimum order quantity of the Supriya Lifescience Limited IPO?

The minimum order quantity and lot size of Supriya Lifescience IPO is 54 shares.

What are the allotment dates for the Supriya Lifescience Limited IPO?

Supriya Lifescience Limited IPO allotment date is December 23.

Who is the registrar of Supriya Lifescience Limited IPO?

Supriya Lifescience Limited IPO registrar is Link Intime India Private Limited

Where is the Supriya Lifescience Limited IPO getting listed?

The shares are proposed to be listed on the BSE and NSE.
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.1.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

ABOUT GROWW